Calmodulin kinase II inhibition disrupts cardiomyopathic effects of enhanced green fluorescent protein
- 1 February 2008
- journal article
- research article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 44 (2) , 405-410
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Lentiviral vector-mediated expression of GFP or Kir2.1 alters the electrophysiology of neonatal rat ventricular myocytes without inducing cytotoxicityAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Gene Transfer of Connexin43 Mutants Attenuates Coupling in CardiomyocytesCirculation Research, 2007
- Death, Cardiac Dysfunction, and Arrhythmias Are Increased by Calmodulin Kinase II in Calcineurin CardiomyopathyCirculation, 2006
- Pancreatic islet function in a transgenic mouse expressing fluorescent proteinJournal of Endocrinology, 2005
- Cardiac transgenesis with the tetracycline transactivator changes myocardial function and gene expressionPhysiological Genomics, 2005
- Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failureCardiovascular Research, 2004
- Temporal changes in ventricular function assessed echocardiographically in conscious and anesthetized miceJournal of the American Society of Echocardiography, 2003
- Inhibition of a mammalian large conductance, calcium‐sensitive K+ channel by calmodulin‐binding peptidesThe Journal of Physiology, 2000
- Immune response to green fluorescent protein: implications for gene therapyGene Therapy, 1999
- Novel tools for localizing ion channels in living cellsTrends in Pharmacological Sciences, 1998